Clinical Dermatology Research JournalISSN: 2576-1439

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Case Report, Clin Dermatol Res J Vol: 1 Issue: 2

A Rarely Seen Entity: Morbus Morbihan Disease

Ayşe Akbaş1*, Fadime Kilinç1, Sibel Orhun Yavuz1, Sertaç Şener1 and Akın Aktaş2
1Ministry of Health Atatürk Training and Research Hospital, Ankara, Turkey
2Department of Dermatology, School of Medicine, Yıldırım Beyazıt University, Turkey
Corresponding author : Ayşe Akbaş
Department of Dermatology, Ataturk Training and Research Hospital, 06800-Bilkent/Ankara, Turkey
Tel: +903122197272/05324064994
E-mail: [email protected]
Received: September 26, 2016 Accepted: October 19, 2016 Published: October 24, 2016
Citation: Akbaş A, Kilinç F, Yavuz SO, Şener S, Aktaş A (2016) A Rarely Seen Entity: Morbus Morbihan Disease.Clin Dermatol Res J 1:2.


Morbus Morbihan disease is granulomatous complication characterized with facial edema occuring due to acne or rosacea. It is resistant to treatment; diagnosis could be difficult. 48 years old male patient applied to our polyclinic with complaint of swelling on left side of his face, around his eye and cheeks, persistent for 6 months. He previously applied to dermatology, dental and Otorhinolaryngology departments in various hospitals but no diagnosis could be made. There was no trauma, exposure to sun, drug use history or symptoms like pain and itch. He was complaining about visual swelling. He had edema stretching from left side of his face to orbital area and mild erythema in his dermatological examination. Our pathology department reevaluated biopsy preparations taken by the center he previously went. Rosacea lymphedema was reported. Doxycycline, ornidazole, ketotifen and flutamide were administered by assuming that patient has Morbus Morbihan disease. In the next examination after one month, it has been observed that edema was diminished. In fourth month, edema decreased a lot. Thus treatment was stopped. The patient was applied again in the following 2 months due to increase at edema on his face. That time 0.5 mg/day isotretinoin treatment started and at third month edema regressed. We found this case appropriate to present to emphasize that it is rare and that it should be considered

Keywords: Morbus morbihan; Rosacea; Lymphedema; Diuretic; Lymph drainage; Tetracycline ornidazole; Isotretinoin

international publisher, scitechnol, subscription journals, subscription, international, publisher, science

Track Your Manuscript

Recommended Conferences

Media Partners


open access